🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 04/09/1996 | 0,1908 USD |
| 06/06/1996 | 0,1622 USD |
| 06/03/1996 | 0,1622 USD |
| 06/12/1995 | 0,1622 USD |
| 05/09/1995 | 0,1622 USD |
| 02/06/1995 | 0,1431 USD |
| 03/03/1995 | 0,1431 USD |
| 02/12/1994 | 0,1431 USD |
| 02/09/1994 | 0,1431 USD |
| 02/06/1994 | 0,1336 USD |
| 02/03/1994 | 0,1336 USD |
| 02/12/1993 | 0,1336 USD |
| 02/09/1993 | 0,1336 USD |
| 02/06/1993 | 0,1193 USD |
| 02/03/1993 | 0,1193 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/02/2009 | 26,63 | 27,25 | 26,28 | 27,22 | +2,33% | 3,65% | 18.588.586 |
| 23/02/2009 | 26,36 | 27,09 | 26,36 | 26,60 | -0,78% | 2,79% | 18.829.730 |
| 20/02/2009 | 26,81 | 27,21 | 26,52 | 26,81 | -1,51% | 2,60% | 18.552.639 |
| 19/02/2009 | 27,61 | 27,67 | 27,16 | 27,22 | -0,38% | 1,87% | 10.332.651 |
| 18/02/2009 | 27,40 | 27,48 | 26,72 | 27,33 | +0,10% | 2,79% | 15.041.210 |
| 17/02/2009 | 26,85 | 27,70 | 26,60 | 27,30 | -0,49% | 4,09% | 21.584.922 |
| 13/02/2009 | 27,93 | 28,05 | 27,21 | 27,43 | -2,01% | 3,01% | 11.000.751 |
| 12/02/2009 | 27,89 | 28,08 | 27,22 | 28,00 | -1,28% | 3,08% | 11.389.769 |
| 11/02/2009 | 27,77 | 28,57 | 27,68 | 28,36 | +2,45% | 3,20% | 10.812.321 |
| 10/02/2009 | 29,07 | 29,25 | 27,54 | 27,68 | -5,35% | 5,87% | 15.057.140 |
| 09/02/2009 | 29,26 | 29,46 | 28,79 | 29,25 | -0,39% | 2,28% | 9.146.839 |
| 06/02/2009 | 28,64 | 29,51 | 28,64 | 29,36 | +2,23% | 3,07% | 11.599.788 |
| 05/02/2009 | 27,29 | 29,06 | 27,29 | 28,72 | +0,67% | 6,50% | 14.368.499 |
| 04/02/2009 | 28,86 | 29,45 | 28,24 | 28,53 | -1,12% | 4,17% | 13.599.372 |
| 03/02/2009 | 28,51 | 29,35 | 27,61 | 28,86 | +6,37% | 6,12% | 24.482.538 |
| 02/02/2009 | 26,80 | 27,61 | 26,72 | 27,13 | -0,42% | 3,35% | 14.703.021 |
| 30/01/2009 | 27,53 | 27,67 | 27,04 | 27,24 | -1,35% | 2,29% | 17.210.675 |
| 29/01/2009 | 27,21 | 27,73 | 27,08 | 27,61 | +0,56% | 2,38% | 12.581.974 |
| 28/01/2009 | 27,54 | 27,78 | 27,08 | 27,46 | +1,45% | 2,53% | 14.200.505 |
| 27/01/2009 | 26,58 | 27,36 | 26,57 | 27,07 | +2,09% | 2,94% | 10.106.178 |
| 26/01/2009 | 26,78 | 27,41 | 26,26 | 26,52 | -1,45% | 4,31% | 14.818.720 |
| 23/01/2009 | 26,47 | 27,05 | 26,27 | 26,91 | +2,73% | 2,96% | 15.603.986 |
| 22/01/2009 | 26,00 | 26,43 | 25,64 | 26,19 | -0,44% | 3,05% | 15.980.428 |
| 21/01/2009 | 26,94 | 27,09 | 25,66 | 26,31 | -1,15% | 5,31% | 19.101.477 |
| 20/01/2009 | 26,84 | 27,56 | 26,56 | 26,61 | -1,06% | 3,73% | 15.407.067 |
| 16/01/2009 | 27,10 | 27,44 | 26,15 | 26,90 | +0,25% | 4,75% | 15.213.711 |
| 15/01/2009 | 26,54 | 26,98 | 26,12 | 26,83 | +1,08% | 3,27% | 13.285.810 |
| 14/01/2009 | 26,65 | 26,97 | 26,15 | 26,55 | -2,18% | 3,08% | 12.828.987 |
| 13/01/2009 | 27,11 | 27,66 | 26,94 | 27,14 | -0,21% | 2,68% | 11.330.138 |
| 12/01/2009 | 27,41 | 27,62 | 27,00 | 27,19 | -0,80% | 2,26% | 9.313.157 |